MedPath

Comparative study of the effect of intravitreal injection of bevacizumab versus simultaneous intravitreal injection of bevacizumab and triamcinolone acetonide

Phase 2
Recruiting
Conditions
Retinal vascular occlusions.
Retinal vascular occlusions
Registration Number
IRCT20130812014333N185
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
58
Inclusion Criteria

All patients who have had retinal vein occlusion in the last 12 weeks based on their history

Exclusion Criteria

History of any previous treatment, including macular laser or intravitreal injection
Having ocular hypertension
Vision better than 20/40 or central macular thickness less than 250 microns
Media opacity
Any type of neovascularization or with retinal arterial occlusion or symptoms in favor of treatment such as cilioretinal and retinal shunts
Any retinal disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vision. Timepoint: First, one and six months after the end of the study. Method of measurement: using Snellen eye chart.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath